U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 20:33:41 GMT 2025
Edited
by admin
on Wed Apr 02 20:33:41 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1|LAMDA
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
PRC4J48944
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Ibramvibart
INN  
Official Name English
VYD-2311
Preferred Name English
VYD2311
Code English
ibramvibart [INN]
Common Name English
immunoglobulin G1-kappa, anti-[severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein, receptor binding domain (RBD)], Homo sapiens monoclonal antibody (Ibramvibart)
Common Name English
Immunoglobulin G1 [435-leucine,441-alanine], anti-(severe acute respiratory syndrome coronavirus 2 spike glycoprotein receptor-binding domain) (human monoclonal VYD2311 ?1-chain), disulfide with human monoclonal VYD2311 ?-chain, dimer
Common Name English
H-gamma1 heavy chain Homo sapiens (1-454) [VH (Homo sapiens IGHV3-21*07 (88.8%) -(IGHD) -IGHJ4*01 (92.9%), CDRIMGT [8.8.17] (26-33.51-58.97-113)) (1-124) -Homo sapiens IGHG1*03, G1m3, nG1m1 CH1 R120, CH3 E12, M14, 9-G1v78 CH3 L107 A114 (CH1 R120 (221) (1
Common Name English
Code System Code Type Description
FDA UNII
PRC4J48944
Created by admin on Wed Apr 02 20:33:41 GMT 2025 , Edited by admin on Wed Apr 02 20:33:41 GMT 2025
PRIMARY
CAS
3031270-42-2
Created by admin on Wed Apr 02 20:33:41 GMT 2025 , Edited by admin on Wed Apr 02 20:33:41 GMT 2025
PRIMARY
INN
13806
Created by admin on Wed Apr 02 20:33:41 GMT 2025 , Edited by admin on Wed Apr 02 20:33:41 GMT 2025
PRIMARY
From To
1_22 1_96
2_22 2_96
2_151 2_207
2_227 4_217
2_268 2_328
1_151 1_207
2_374 2_432
3_22 3_90
3_140 3_199
4_22 4_90
4_140 4_199
1_227 3_217
1_233 2_233
1_236 2_236
1_268 1_328
1_374 1_432
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_304
N 2_304
Related Record Type Details
TARGET ORGANISM->INHIBITOR
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [3_1] [4_1] N-TERMINUS Q PIDOLIC ACID SZB83O1W42
AMINO ACID REMOVAL [1_454] [2_454] C-TERMINUS K LYSINE K3Z4F929H6
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL